Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

In “The Last Alzheimer’s Patient,” CNN chief medical correspondent follows Alzheimer’s patient Cici Zerbe who says her ...

"The results of this study we're talking about are disturbing," said Dr. Ted Huey, Director of Butler Hospitals' memory and ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...

The new estimate is based on a new study that found a higher lifetime risk than previously thought: After age 55, people have ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...